Anti-Rheumatic Rx
Day 4 was a half day closeout to the EULAR 2023 Congress. For me the big presentations were the late breaking abstracts, although there were other review and abstract sessions for those remaining.…
Some subjects in rheumatology seem to create contention the more they get explored, and one of those areas is a traditional crowd favourite for discussion at EULAR - clinically suspect arthralgias.…
Day 3 was a sunny warm day in Milan at the 2023 EULAR Congress meeting. Here are a few of my favorite abstracts from today.
Rheumatoid Factor Lowering Predicts Improved Outcomes in RA. Abstract…
Day 2 at the international EULAR Congress meeting is always bigger and busier. There are more sessions to choose from, more bodies fighting for space on the escalators and at the lunch lines,…
Interstitial lung disease (ILD) is a severe extra articular manifestation of RA, with limited treatment strategies and poor prognosis. While for a long time RA treatments, such as methotrexate (MTX…
Podcasts
Current & Future Biomarkers in SLE - Dr. Andrea Fava
Rheum Chapter Notes (4.26.2024)
Spondyloarthritis Faculty Panel Q&A
googletag.cmd.push(function() { googletag.display('div-gpt-ad-1601919334745-0'); });
Poster Hall